MEDCAC weighs in on treatment-resistant depression

CMS's Medicare Evidence Development & Coverage Advisory Committee agreed there was a standard definition of treatment-resistant depression (TRD) and outlined criteria that should be included in clinical trials of interventions for the disease.

On

Read the full 348 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE